ADAR1 Capital Management »

Sutro Biopharma shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $776k 67k 11.57

More positions owned by ADAR1 Capital Management

Abivax Sa Sponsored Ads (ABVX)
Protagonist Therapeutics (PTGX)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Avidity Biosciences Ord (RNA)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Cytokinetics Com New (CYTK)
Septerna (SEPN)
Arbutus Biopharma (ABUS)
Zai Lab Adr (ZLAB)
Terns Pharmaceuticals (TERN)
Cytomx Therapeutics (CTMX)
Celldex Therapeutics Com New (CLDX)
Rapt Therapeutics Com New (RAPT)

View all positions for ADAR1 Capital Management

Top funds holding Sutro Biopharma

Affinity Asset Advisors
Vanguard Group
Acadian Asset Management
Samsara BioCapital
Eversept Partners
Opaleye Management
Point72 Asset Management
Tang Capital Management
Renaissance Technologies
GSA Capital Partners
Marshall Wace
Geode Capital Management
Longwood Capital Partners
ADAR1 Capital Management
Fisher Investments

View all funds holding Sutro Biopharma